Evidence map›Paper›PMID 31803166›Full record

ArticleFrontiers in microbiology2019

Antifungal Activity of a Hydroethanolic Extract From

Bruna Vidal Bonifácio, Taissa Vieira Machado Vila, Isadora Fantacini Masiero, Patrícia Bento da Silva, Isabel Cristiane da Silva, Érica de Oliveira Lopes, Matheus Aparecido Dos Santos Ramos, Leonardo Perez de Souza, Wagner Vilegas, Fernando Rogério Pavan and 3 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evaluation ofAntioxidants (Basel, Switzerland) · 2022
    Article
  7. Promising Antifungal Activity ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. International journal of molecular sciences · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bruna Vidal BonifácioSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Taissa Vieira Machado VilaDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio (UTSA), San Antonio, TX, United States.
Isadora Fantacini MasieroSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Patrícia Bento da SilvaSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Isabel Cristiane da SilvaSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Érica de Oliveira LopesSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Matheus Aparecido Dos Santos RamosSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Leonardo Perez de SouzaInstitute of Chemistry, São Paulo State University (UNESP), Araraquara, Brazil.
Wagner VilegasInstitute of Biosciences, São Paulo State University (UNESP), São Vicente, Brazil.
Fernando Rogério PavanSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
Marlus ChorilliSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
José Luis Lopez-RibotDepartment of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio (UTSA), San Antonio, TX, United States.
Taís Maria BauabSchool of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.

Funding

Development of novel chemical series of Candida albicans biofilm inhibitorsR01AI119554 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L., MCHARDY, STANTON FURST · 2015 to 2019
$1.8M
Targeting virulence against oral candidiasis in HIV/AIDSR01DE023510 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2013 to 2017
$1.8M
NIAID NIH HHS R01 AI119554NIDCR NIH HHS R01 DE023510
6 · The paper itself

Abstract

We have previously reported on the activity of different extracts from

Indexed as

Astronium urundeuvaCandida sp. biofilmcheckerboardresistancevulvovaginal candidiasis

Identifiers

PMID31803166
PMCPMC6873212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.